MedPath

Dexmedetomidine

Generic Name
Dexmedetomidine
Brand Names
Dexdor, Igalmi, Precedex, Dexmedetomidine Accord
Drug Type
Small Molecule
Chemical Formula
C13H16N2
CAS Number
113775-47-6
Unique Ingredient Identifier
67VB76HONO
Background

An agonist of receptors, adrenergic alpha-2 that is used in veterinary medicine for its analgesic and sedative properties. It is the racemate of dexmedetomidine.

Indication

Administered intravenously, dexmedetomidine is indicated for the sedation of initially intubated and mechanically ventilated patients during treatment in intensive care settings, and for the sedation of non-intubated patients prior to and/or during surgery and other procedures. It is also available as a buccally- or sublingually-administered dissolvable film for the acute treatment of agitation associated with schizophrenia or bipolar I or II disorder.

Associated Conditions
Agitation, Alcohol Withdrawal Syndrome
Associated Therapies
-

Continuous Nerve Block Block vs Combination of Single Block Plus Intravenous Lidocaine for Postoperative Pain.

Phase 4
Terminated
Conditions
Postoperative Pain
Interventions
Procedure: Continuous Erector Spinae Plane Nerve Block
Procedure: Single Erector Spinae Plane Nerve Block
Procedure: Continuous Quadratus Lumborum Nerve Block
Procedure: Single Quadratus Lumborum Nerve Block
Drug: Lidocaine IV
Drug: Ropivacaine 0.5% Injectable Solution
Drug: Lidocaine
Drug: Dexamethasone
Drug: Dexmedetomidine
First Posted Date
2019-12-23
Last Posted Date
2023-09-13
Lead Sponsor
Jeremy Kearns
Target Recruit Count
17
Registration Number
NCT04208516
Locations
🇺🇸

UPMC Shadyside Hospital, Pittsburgh, Pennsylvania, United States

Closed Loop Acoustic Stimulation During Sedation With Dexmedetomidine

Not Applicable
Active, not recruiting
Conditions
Sleep
Sedation Complication
Interventions
Radiation: MRI
Diagnostic Test: Quantitative Sensory Testing (QST)
Diagnostic Test: Home sleep study
Other: Acoustic stimulation (65db) up-slope of EEG with QST
Other: Acoustic stimulation (65db) down-slope of EEG with QST
Other: 0 db with QST
Drug: Dexmedetomidine
Other: Breathe-Squeeze Task
First Posted Date
2019-12-20
Last Posted Date
2022-12-02
Lead Sponsor
Washington University School of Medicine
Target Recruit Count
20
Registration Number
NCT04206059
Locations
🇺🇸

Washington University School of Medicine/Barnes-Jewish Hospital, Saint Louis, Missouri, United States

Dexmedetomidine and Outcomes of Elderly Admitted to ICU After Surgery

Not Applicable
Recruiting
Conditions
Surgery
Overall Survival
Elderly
Intensive Care Unit
Dexmedetomidine
Interventions
First Posted Date
2019-12-19
Last Posted Date
2023-09-21
Lead Sponsor
Peking University First Hospital
Target Recruit Count
1410
Registration Number
NCT04204798
Locations
🇨🇳

Peking University First Hospital, Beijing, Beijing, China

Lymphatic System Health in Alzheimer's Disease

Phase 1
Withdrawn
Conditions
Alzheimer Disease
Interventions
First Posted Date
2019-12-19
Last Posted Date
2022-09-28
Lead Sponsor
Neurological Associates of West Los Angeles
Registration Number
NCT04205539
Locations
🇺🇸

Westwood Open MRI, Los Angeles, California, United States

🇺🇸

Neurological Associates of West Los Angeles, Santa Monica, California, United States

Epidural Anesthesia for Gynecological Surgeries

Phase 4
Completed
Conditions
Epidural Analgesics for Comparison
Interventions
First Posted Date
2019-11-22
Last Posted Date
2021-08-03
Lead Sponsor
Cairo University
Target Recruit Count
150
Registration Number
NCT04174872
Locations
🇪🇬

Department of Anesthesia, Surgical ICU, and Pain Management, Cairo, Egypt

Articaine vs Dexmedetomidine Supplemented Articaine

Early Phase 1
Completed
Conditions
Renal Failure
Interventions
First Posted Date
2019-11-20
Last Posted Date
2019-11-20
Lead Sponsor
Ain Shams University
Target Recruit Count
50
Registration Number
NCT04171349
Locations
🇪🇬

Ain Shams University hosptal, Cairo, Abbasya, Egypt

Dexmedetomidine Sedation in Orthopedic Surgery

Phase 2
Conditions
Hallux Valgus and Bunion
Sedation
Interventions
First Posted Date
2019-11-04
Last Posted Date
2020-01-30
Lead Sponsor
Asklepieion Voulas General Hospital
Target Recruit Count
60
Registration Number
NCT04149626
Locations
🇬🇷

Asklepieion Hospital of Voula, Athens, Greece

Dexmedetomidine and Propofol in the Treatment of Emergence Agitation

Early Phase 1
Conditions
Emergence Agitation
Interventions
First Posted Date
2019-10-29
Last Posted Date
2020-01-14
Lead Sponsor
RenJi Hospital
Target Recruit Count
120
Registration Number
NCT04142840
Locations
🇨🇳

Renji Hospital,Shanghai Jiao Tong University,School of Medicine, Shanghai, Shanghai, China

Comparison of the Effects of Dexmedetomidine and Propofol on the Cardiovascular Autonomic Nervous System During Spinal Anesthesia

Not Applicable
Completed
Conditions
Spinal Anesthesia
Autonomic Nervous System
Interventions
First Posted Date
2019-10-29
Last Posted Date
2022-02-18
Lead Sponsor
Ajou University School of Medicine
Target Recruit Count
60
Registration Number
NCT04142502
Locations
🇰🇷

Ajou university school of medicine, Suwon, Gyeonggi-do, Korea, Republic of

Comparison Of Dexmedetomidine, Fentanyl And Lignocaine In Attenuation Of Hemodynamic Response To Direct Laryngoscopy And Intubation In Patient Undergoing Laparoscopic Cholecystectomy

Not Applicable
Conditions
Laparoscopic Cholecystectomy
Interventions
First Posted Date
2019-10-24
Last Posted Date
2020-02-07
Lead Sponsor
Sana Urooj
Target Recruit Count
30
Registration Number
NCT04138472
Locations
🇵🇰

DUHS, Civil hospital Karachi (CHK), Karachi, Sindh, Pakistan

© Copyright 2025. All Rights Reserved by MedPath